Frankfurt - Delayed Quote EUR

Getinge AB (publ) (GTN.F)

17.61

+0.15

+(0.83%)

At close: May 16 at 8:05:27 AM GMT+2

Getinge AB (GNGBF) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid Currency Challenges

Getinge AB (GNGBF) reports robust sales growth and margin improvements, despite facing currency headwinds and decreased free cash flow.

GuruFocus.com 23 days ago

GNGBY
3 European Growth Companies With Insider Ownership Up To 22%

Amid heightened global trade tensions and economic uncertainty, European markets have experienced significant declines, with the STOXX Europe 600 Index seeing its largest drop in five years. In such volatile conditions, companies with strong insider ownership can be appealing to investors as this often indicates confidence from those closest to the business.

Simply Wall St. last month

GNGBF

GNGBY

MOL.MI
Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova

Getinge is phasing out its surgical perfusion business to focus on the ECMO market.

Medical Device Network 2 months ago

GNGBY

LIVN

GLDAF
Getinge plans to leave surgical perfusion

The company will re-allocate resources and focus on more lucrative areas with higher growth potential.

Medical Device Network 2 months ago

GNGBY

LIVN
Getinge AB (GNGBF) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Shifts

Getinge AB (GNGBF) reports robust sales growth and strategic restructuring amid market challenges and quality-related costs.

GuruFocus.com 3 months ago

GNGBY
Getinge exits surgical perfusion, creating opportunity for Livanova

Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

MedTech Dive 3 months ago

GNGBY
Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

"In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also organically, with positive performance in all regions", says Mattias Perjos, CEO of Getinge.

PR Newswire 3 months ago

GNGBF

GNGBY
Getinge installs surgical workflow portfolio at UT Health San Antonio in Texas

The installation aims to improve efficiency and patient safety across various care settings.

Hospital Management 5 months ago

GNGBY
Two hybrid ORs inaugurated in ASST Sette Laghi hospital, Italy

The multi-modality ORs are designed to cater to complex procedures.

Hospital Management 5 months ago

GNGBY
FDA warns providers on Getinge devices tied to 17 serious injuries

Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.

MedTech Dive 5 months ago

GNGBY
Paragonix wins FDA nod for portable kidney perfusion device

The KidneyVault system is a hypothermic perfusion device with digital monitoring capabilities for preserving and transporting donor kidneys.

Medical Device Network 6 months ago

GNGBY
Getinge AB (GNGBF) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Getinge AB (GNGBF) reports strong order intake and strategic acquisitions, while addressing supply chain and margin pressures.

GuruFocus.com 6 months ago

GNGBY
Getinge completes Paragonix Technologies acquisition

Paragonix is engaged in developing, manufacturing, and providing services in the organ transplant industry.

Medical Device Network 7 months ago

GNGBY
Getinge completes the acquisition of Paragonix Technologies

On August 22, 2024, Getinge announced that it had entered into an agreement to acquire Paragonix Technologies, Inc., a leading U.S. company in organ transport products and services, for a total purchase price estimated at USD 477 million, including upfront and currently estimated earn-outs.

PR Newswire 7 months ago

GNGBF

GNGBY
Getinge to buy Paragonix organ-preserving tech for up to $477M

Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.

MedTech Dive 8 months ago

GNGBY
FDA issues 510(k) clearance for Getinge’s Talis +ACG software

The software suite includes Talis-Anesthesia, Talis-Perfusion, Talis-RemoteView, and Talis-ECMO applications.

Medical Device Network 10 months ago

GNGBY

Performance Overview

Return	GTN.F	OMX Stockholm 30 Index (^OMX)
YTD	+51.19%	+2.45%
1-Year	+46.45%	-2.48%
3-Year	+39.95%	+26.92%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Getinge AB (publ) (GTN.F)

Getinge AB (GNGBF) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid Currency Challenges

3 European Growth Companies With Insider Ownership Up To 22%

Getinge’s surgical perfusion market exit ‘opens door’ for LivaNova

Getinge plans to leave surgical perfusion

Getinge AB (GNGBF) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Shifts

Getinge exits surgical perfusion, creating opportunity for Livanova

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

Getinge installs surgical workflow portfolio at UT Health San Antonio in Texas

Two hybrid ORs inaugurated in ASST Sette Laghi hospital, Italy

FDA warns providers on Getinge devices tied to 17 serious injuries

Paragonix wins FDA nod for portable kidney perfusion device

Getinge AB (GNGBF) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Getinge completes Paragonix Technologies acquisition

Getinge completes the acquisition of Paragonix Technologies

Getinge to buy Paragonix organ-preserving tech for up to $477M

FDA issues 510(k) clearance for Getinge’s Talis +ACG software

Performance Overview